269 related articles for article (PubMed ID: 19671159)
1. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
Pickard MR; Green AR; Ellis IO; Caldas C; Hedge VL; Mourtada-Maarabouni M; Williams GT
Breast Cancer Res; 2009; 11(4):R60. PubMed ID: 19671159
[TBL] [Abstract][Full Text] [Related]
2. Candidate tumour suppressor Fau regulates apoptosis in human cells: an essential role for Bcl-G.
Pickard MR; Mourtada-Maarabouni M; Williams GT
Biochim Biophys Acta; 2011 Sep; 1812(9):1146-53. PubMed ID: 21550398
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis regulators Fau and Bcl-G are down-regulated in prostate cancer.
Pickard MR; Edwards SE; Cooper CS; Williams GT
Prostate; 2010 Oct; 70(14):1513-23. PubMed ID: 20687224
[TBL] [Abstract][Full Text] [Related]
4. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
[TBL] [Abstract][Full Text] [Related]
5. FAU regulates carboplatin resistance in ovarian cancer.
Moss EL; Mourtada-Maarabouni M; Pickard MR; Redman CW; Williams GT
Genes Chromosomes Cancer; 2010 Jan; 49(1):70-7. PubMed ID: 19830698
[TBL] [Abstract][Full Text] [Related]
6. Regulation of apoptosis by fau revealed by functional expression cloning and antisense expression.
Mourtada-Maarabouni M; Kirkham L; Farzaneh F; Williams GT
Oncogene; 2004 Dec; 23(58):9419-26. PubMed ID: 15543234
[TBL] [Abstract][Full Text] [Related]
7. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
van Roosmalen W; Le Dévédec SE; Golani O; Smid M; Pulyakhina I; Timmermans AM; Look MP; Zi D; Pont C; de Graauw M; Naffar-Abu-Amara S; Kirsanova C; Rustici G; Hoen PA; Martens JW; Foekens JA; Geiger B; van de Water B
J Clin Invest; 2015 Apr; 125(4):1648-64. PubMed ID: 25774502
[TBL] [Abstract][Full Text] [Related]
9. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
[TBL] [Abstract][Full Text] [Related]
10. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
Ren L; Deng B; Saloura V; Park JH; Nakamura Y
Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
[TBL] [Abstract][Full Text] [Related]
11. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
[TBL] [Abstract][Full Text] [Related]
12. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
13. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
Beke L; Kig C; Linders JT; Boens S; Boeckx A; van Heerde E; Parade M; De Bondt A; Van den Wyngaert I; Bashir T; Ogata S; Meerpoel L; Van Eynde A; Johnson CN; Beullens M; Brehmer D; Bollen M
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26431963
[TBL] [Abstract][Full Text] [Related]
14. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
[TBL] [Abstract][Full Text] [Related]
15. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
[TBL] [Abstract][Full Text] [Related]
16. Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.
Speers C; Zhao SG; Kothari V; Santola A; Liu M; Wilder-Romans K; Evans J; Batra N; Bartelink H; Hayes DF; Lawrence TS; Brown PH; Pierce LJ; Feng FY
Clin Cancer Res; 2016 Dec; 22(23):5864-5875. PubMed ID: 27225691
[TBL] [Abstract][Full Text] [Related]
17. The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.
Kuner R; Fälth M; Pressinotti NC; Brase JC; Puig SB; Metzger J; Gade S; Schäfer G; Bartsch G; Steiner E; Klocker H; Sültmann H
J Mol Med (Berl); 2013 Feb; 91(2):237-48. PubMed ID: 22945237
[TBL] [Abstract][Full Text] [Related]
18. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
[TBL] [Abstract][Full Text] [Related]
19. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
Merino D; Lok SW; Visvader JE; Lindeman GJ
Oncogene; 2016 Apr; 35(15):1877-87. PubMed ID: 26257067
[TBL] [Abstract][Full Text] [Related]
20. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
